Actelion Drug to be Reviewed in EU – Analyst Blog

By | November 26, 2012
0 Comment

The European Medicines Agency (EMA) recently accepted the Marketing Authorisation Application (MAA) filed by Actelion ( ALIOF ) seeking approval for its pulmonary arterial hypertension

Read More:
Actelion Drug to be Reviewed in EU – Analyst Blog

Related posts:

  1. Actelion Files NDA for Macitentan – Analyst Blog
  2. FDA Accepts Merck’s Sleep Drug NDA – Analyst Blog
  3. Glaxo’s Anthrax Drug Gets FDA Nod – Analyst Blog
  4. AstraZeneca’s RA Drug Disappoints – Analyst Blog